Reference
Myall NJ, et al. Safety of lorlatinib following alectinib-induced pneumonitis in two patients with ALK-rearranged non-small cell lung cancer: A case series. Translational Lung Cancer Research 10: 487-495, No. 1, Jan 2021. Available from: URL: http://doi.org/10.21037/tlcr-20-564
Rights and permissions
About this article
Cite this article
Alectinib/lorlatinib. Reactions Weekly 1860, 29 (2021). https://doi.org/10.1007/s40278-021-97484-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-97484-1